These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine. Hundeshagen H Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704 [No Abstract] [Full Text] [Related]
25. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. Ringel MD; Ladenson PW J Clin Endocrinol Metab; 1996 May; 81(5):1724-5. PubMed ID: 8626823 [TBL] [Abstract][Full Text] [Related]
26. An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma. Regalbuto C; Tumminia A; Malandrino P; Salamone S; Pezzino V J Endocrinol Invest; 2010 Jun; 33(6):434-5. PubMed ID: 20631495 [No Abstract] [Full Text] [Related]
27. 131I treatment of thyroid papillary carcinoma in a patient with renal failure. Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192 [TBL] [Abstract][Full Text] [Related]
28. Uptake of I-131 in the biliary tract: a potential cause of a false-positive result of scintiscan. Carlisle M; Cortés A; McDougall IR Clin Nucl Med; 1998 Aug; 23(8):524-7. PubMed ID: 9712386 [TBL] [Abstract][Full Text] [Related]
29. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma. Silberstein EB J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976 [TBL] [Abstract][Full Text] [Related]
30. An unusual false-positive scan in a patient with pericardial effusion. Geatti O; Shapiro B; Orsolon PG; Mirolo R; Di Donna A Clin Nucl Med; 1994 Aug; 19(8):678-82. PubMed ID: 7955744 [TBL] [Abstract][Full Text] [Related]
32. Thymus accumulation of I-131 after therapeutic dose for thyroid carcinoma. Muratet JP; Giraud P Clin Nucl Med; 1996 Sep; 21(9):736-7. PubMed ID: 8879880 [No Abstract] [Full Text] [Related]
33. How to distinguish between radioiodine accumulation in a laryngocele from a radioiodine-concentrating thyroid remnant after thyroidectomy for papillary carcinoma. Nièpomniszcze H; Schere D Thyroid; 2004 Oct; 14(10):867-8. PubMed ID: 15588387 [No Abstract] [Full Text] [Related]
34. Differentiated thyroid carcinoma: Incremental diagnostic value of Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475 [TBL] [Abstract][Full Text] [Related]
35. Long-term survival of thyroid carcinoma with metastatic disease treated with radioiodine. Lackey RW Int J Nucl Med Biol; 1978; 5(6):255-9. PubMed ID: 738840 [No Abstract] [Full Text] [Related]
36. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I. Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552 [TBL] [Abstract][Full Text] [Related]
37. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone. Rudavsky AZ; Freeman LM J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223 [No Abstract] [Full Text] [Related]